Literature DB >> 25980678

Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1-3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP-recipient natural killer cells.

Sheila López-Cobo1, Gema Romera-Cárdenas1, Eva M García-Cuesta1, Hugh T Reyburn1, Mar Valés-Gómez1.   

Abstract

After immune interactions, membrane fragments can be transferred between cells. This fast transfer of molecules is transient and shows selectivity for certain proteins; however, the constraints underlying acquisition of a protein are unknown. To characterize the mechanism and functional consequences of this process in natural killer (NK) cells, we have compared the transfer of different NKG2D ligands. We show that human NKG2D ligands can be acquired by NK cells with different efficiencies. The main findings are that NKG2D ligand transfer is related to immune activation and receptor-ligand interaction and that NK cells acquire these proteins during interactions with target cells that lead to degranulation. Our results further demonstrate that NK cells that have acquired NKG2D ligands can stimulate activation of autologous NK cells. Surprisingly, NK cells can also re-transfer the acquired molecule to autologous effector cells during this immune recognition that leads to their death. These data demonstrate that transfer of molecules occurs as a consequence of immune recognition and imply that this process might play a role in homeostatic tuning-down of the immune response or be used as marker of interaction.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  NKG2D; glycosyl-phosphatidyl-inositol-anchored proteins; human natural killer cells; immune synapse; trogocytosis

Mesh:

Substances:

Year:  2015        PMID: 25980678      PMCID: PMC4552502          DOI: 10.1111/imm.12482

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner.

Authors:  D Hudrisier; J Riond; H Mazarguil; J E Gairin; E Joly
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

2.  Active trans-synaptic capture of membrane fragments by natural killer cells.

Authors:  Julie Tabiasco; Eric Espinosa; Denis Hudrisier; Etienne Joly; Jean-Jacques Fournié; Alain Vercellone
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

3.  The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cell.

Authors:  Sandrine Daubeuf; Margaret A Lindorfer; Ronald P Taylor; Etienne Joly; Denis Hudrisier
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

4.  Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells.

Authors:  Sven Mesecke; Doris Urlaub; Hauke Busch; Roland Eils; Carsten Watzl
Journal:  Sci Signal       Date:  2011-05-31       Impact factor: 8.192

5.  Trogocytosis-based generation of suppressive NK cells.

Authors:  Julien Caumartin; Benoit Favier; Marina Daouya; Christine Guillard; Philippe Moreau; Edgardo D Carosella; Joel LeMaoult
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

6.  Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.

Authors:  Pedro Roda-Navarro; María Mittelbrunn; Mara Ortega; Duncan Howie; Cox Terhorst; Francisco Sánchez-Madrid; Elena Fernández-Ruiz
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

7.  A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.

Authors:  Omodele Ashiru; Sheila López-Cobo; Lola Fernández-Messina; Samuel Pontes-Quero; Rachele Pandolfi; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

Review 8.  New prospects on the NKG2D/NKG2DL system for oncology.

Authors:  Evelyn Ullrich; Joachim Koch; Adelheid Cerwenka; Alexander Steinle
Journal:  Oncoimmunology       Date:  2013-10-25       Impact factor: 8.110

9.  Preferential transfer of certain plasma membrane proteins onto T and B cells by trogocytosis.

Authors:  Sandrine Daubeuf; Anne Aucher; Christine Bordier; Audrey Salles; Laurent Serre; Gérald Gaibelet; Jean-Charles Faye; Gilles Favre; Etienne Joly; Denis Hudrisier
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

10.  The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope.

Authors:  Mar Valés-Gómez; Adam Winterhalter; Pedro Roda-Navarro; Albert Zimmermann; Louise Boyle; Hartmut Hengel; Andrew Brooks; Hugh T Reyburn
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

View more
  7 in total

Review 1.  Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma.

Authors:  Jian Wang; Cun-Di Li; Lin Sun
Journal:  Biomolecules       Date:  2020-02-14

2.  Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.

Authors:  Eric Alves; Emily McLeish; Pilar Blancafort; Jerome D Coudert; Silvana Gaudieri
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

Review 3.  Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.

Authors:  Hamid Khodayari; Saeed Khodayari; Elmira Ebrahimi; Farimah Hadjilooei; Miko Vesovic; Habibollah Mahmoodzadeh; Tomo Saric; Wilfried Stücker; Stefaan Van Gool; Jürgen Hescheler; Karim Nayernia
Journal:  Cancer Immunol Immunother       Date:  2021-07-04       Impact factor: 6.968

Review 4.  NK Cell Interaction With Platelets and Myeloid Cells in the Tumor Milieu.

Authors:  Stefanie Maurer; Lucas Ferrari de Andrade
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

Review 5.  Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Authors:  Antonio Valeri; Almudena García-Ortiz; Eva Castellano; Laura Córdoba; Elena Maroto-Martín; Jessica Encinas; Alejandra Leivas; Paula Río; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

6.  Expression and prognostic significance of unique ULBPs in pancreatic cancer.

Authors:  Jiong Chen; Xing-Xing Zhu; Hong Xu; Heng-Zhong Fang; Jin-Qian Zhao
Journal:  Onco Targets Ther       Date:  2016-08-25       Impact factor: 4.147

Review 7.  More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Authors:  Andrew P Trembath; Mary A Markiewicz
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.